Eagle Pharmaceuticals Inc... (EGRX)
0.94
-0.06 (-6.00%)
At close: Mar 27, 2025, 10:53 AM
0.88
-6.88%
After-hours: Mar 28, 2025, 04:00 PM EDT
Eagle Pharmaceuticals Balance Sheet Statement
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 55.32M | 97.66M | 103.16M | 109.78M | 78.79M | 114.66M | 52.82M | 79.08M | 22.72M | 10.46M | 5.07M |
| Short-Term Investments | n/a | 4.98M | n/a | n/a | n/a | n/a | n/a | n/a | 20M | n/a | 1.5M |
| Long-Term Investments | 10.01M | 6.03M | 12.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 15.72M | 4.25M | 5.01M | 3.91M | 694K | 124K | 136K | 143K | 45K | 217.93K | 76.32K |
| Receivables | 73.44M | 41.15M | 51.12M | 48M | 66.49M | 53.82M | 42.19M | 26.27M | 7.3M | 5.12M | 1.58M |
| Inventory | 47.79M | 21.91M | 8.07M | 6.57M | 8.3M | 5.12M | 2.74M | 15.04M | 1.29M | 1.87M | 86.88K |
| Other Current Assets | 12.2M | 10.47M | 3.72M | 28.76M | 20.39M | 29.64M | 22.36M | 3.51M | 1.71M | 1.9M | 630.38K |
| Total Current Assets | 188.75M | 172.61M | 166.06M | 179.45M | 163.84M | 188.7M | 109.11M | 122.26M | 53.02M | 17.48M | 8.86M |
| Property-Plant & Equipment | 1.17M | 1.64M | 2.08M | 2.2M | 2.4M | 6.82M | 3.32M | 2.21M | 344K | 402.29K | 496.73K |
| Goodwill & Intangibles | 163.36M | 50.41M | 52.66M | 55.33M | 57.85M | 63.06M | 72.36M | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 217.41M | 81.13M | 87.13M | 75.11M | 74.76M | 81.36M | 104.46M | 2.35M | 389K | 620.21K | 573.05K |
| Total Assets | 406.16M | 253.73M | 253.19M | 254.55M | 238.6M | 270.06M | 213.57M | 124.61M | 53.41M | 18.1M | 9.44M |
| Account Payables | 18.99M | 16.43M | 6.27M | 5.46M | 9.92M | 11.98M | 14.72M | 3.86M | 4.06M | 1.19M | 1.44M |
| Deferred Revenue | n/a | 25.36M | 20.74M | 26.06M | 21.71M | 15.39M | n/a | 6M | 6.58M | 10.02M | 9.5M |
| Short-Term Debt | 7.78M | 26.92M | 9.12M | 5M | 6.25M | 4.88M | n/a | n/a | n/a | n/a | 8.57M |
| Other Current Liabilities | 79.13M | 31.03M | 22.69M | 28.36M | 23.52M | 30.45M | 26.25M | 24.41M | 9.67M | 3.13M | 1.37M |
| Total Current Liabilities | 111.09M | 74.38M | 38.09M | 38.82M | 39.69M | 47.3M | 40.22M | 34.26M | 20.32M | 14.34M | 20.88M |
| Long-Term Debt | 60.01M | 2.9M | 29.09M | 36.56M | 38.16M | 42.91M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.51M | -1K | n/a | n/a | n/a | 709K | 22.13M | n/a | n/a | 1.71M | 654.53K |
| Total Long-Term Liabilities | 61.51M | 2.9M | 29.09M | 36.56M | 38.16M | 43.61M | 22.13M | 9.86M | 10.64M | 1.71M | 654.53K |
| Total Liabilities | 172.6M | 77.28M | 67.18M | 75.38M | 77.84M | 90.92M | 62.34M | 34.26M | 20.32M | 16.05M | 21.54M |
| Total Debt | 67.79M | 25.61M | 37.09M | 38.56M | 44.41M | 47.78M | n/a | n/a | n/a | n/a | 8.57M |
| Common Stock | 18K | 17K | 17K | 17K | 17K | 16K | 16K | 15K | 14K | 3.05K | 1.65K |
| Retained Earnings | 111.5M | 75.86M | 84.49M | 72.5M | 58.19M | 26.28M | -25.66M | -107.11M | -104.18M | -102.14M | -95.54M |
| Comprehensive Income | -1.11M | -94K | -0.00 | 0.00 | -0.00 | 0.00 | -0.00 | n/a | 0.00 | -89.98M | -81.34M |
| Shareholders Equity | 233.56M | 176.45M | 186.01M | 179.17M | 160.76M | 179.14M | 151.23M | 90.34M | 33.1M | 2.05M | -12.1M |
| Total Investments | 10.01M | 4.98M | 12.2M | n/a | n/a | n/a | n/a | n/a | 20M | n/a | 1.5M |